ACHN - Achillion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5947.02M
Enterprise Value 3795.3M
Trailing P/E N/A
Forward P/E 1-8.67
PEG Ratio (5 yr expected) 1-0.66
Price/Sales (ttm)N/A
Price/Book (mrq)4.35
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-10.06

Trading Information

Stock Price History

Beta (5Y Monthly) 1.59
52-Week Change 3165.10%
S&P500 52-Week Change 315.46%
52 Week High 37.01
52 Week Low 32.35
50-Day Moving Average 36.24
200-Day Moving Average 35.37

Share Statistics

Avg Vol (3 month) 34.16M
Avg Vol (10 day) 3N/A
Shares Outstanding 5140.09M
Float 118.79M
% Held by Insiders 10.21%
% Held by Institutions 188.11%
Shares Short (Jan 14, 2020) 416.38M
Short Ratio (Jan 14, 2020) 47.89
Short % of Float (Jan 14, 2020) 411.98%
Short % of Shares Outstanding (Jan 14, 2020) 411.69%
Shares Short (prior month Dec 12, 2019) 412.68M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.09%
Return on Equity (ttm)-29.96%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-50.12M
EBITDA -79.08M
Net Income Avi to Common (ttm)-74.57M
Diluted EPS (ttm)-0.54
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)153.69M
Total Cash Per Share (mrq)1.1
Total Debt (mrq)2.27M
Total Debt/Equity (mrq)1.05
Current Ratio (mrq)8.96
Book Value Per Share (mrq)1.55

Cash Flow Statement

Operating Cash Flow (ttm)-59.98M
Levered Free Cash Flow (ttm)-33.7M